# Lianyungang Kangle Pharmaceutical Co., Ltd. – FDA Inspection, Sep 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/lianyungang-kangle-pharmaceutical-co-ltd/d78f33d3-e13d-4ab4-bdd8-f5ba1a4c5cb7
Source feed: FDA_Inspections

> FDA inspection 1291764 of Lianyungang Kangle Pharmaceutical Co., Ltd., September 19, 2025. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291764
- Company Name: Lianyungang Kangle Pharmaceutical Co., Ltd.
- Inspection Date: 2025-09-19
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1149183 - 2019-05-31
- FDA Inspection 981645 - 2016-07-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)

Company: https://www.keypedia.com/companies/lianyungang-kangle-pharmaceutical-co-ltd/40be34e0-fb10-4928-81cf-1717686c5d2e

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
